_version_ |
1797326758554370048
|
collection |
DOAJ
|
first_indexed |
2024-03-08T06:28:47Z
|
format |
Article
|
id |
doaj.art-e23aa1aeece74d2ba050716e1f300f82
|
institution |
Directory Open Access Journal
|
issn |
2051-1426
|
language |
English
|
last_indexed |
2024-03-08T06:28:47Z
|
publishDate |
2024-01-01
|
publisher |
BMJ Publishing Group
|
record_format |
Article
|
series |
Journal for ImmunoTherapy of Cancer
|
spelling |
doaj.art-e23aa1aeece74d2ba050716e1f300f822024-02-03T12:40:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262024-01-0112110.1136/jitc-2022-004762corr1Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockadehttps://jitc.bmj.com/content/12/1/e004762corr1.full
|
spellingShingle |
Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
Journal for ImmunoTherapy of Cancer
|
title |
Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
|
title_full |
Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
|
title_fullStr |
Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
|
title_full_unstemmed |
Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
|
title_short |
Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
|
title_sort |
correction oncolytic virus expressing pd 1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with ctla 4 or tim 3 blockade
|
url |
https://jitc.bmj.com/content/12/1/e004762corr1.full
|